logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help? | Journal Article / Commentary | MSF Science Portal
Journal Article
|Commentary

Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?

Deen JL, Lopez AMZ, Kanungo S, Wang XY, Ahn DD, Tapia M, Grais RF
Download

Similar Content
Commentary
|Commentary
Effectiveness of oral cholera vaccine in Haiti
2015 March 01 • Lancet Global Health
Loading...
Loading...
Abstract
There are two internationally available WHO-prequalified oral rotavirus vaccines (Rotarix and RotaTeq), two rotavirus vaccines licensed in India (Rotavac and Rotasiil), one in China (Lanzhou lamb rotavirus vaccine) and one in Vietnam (Rotavin-M1), and several candidates in development. Rotavirus vaccination has been rolled out in Latin American countries and is beginning to be deployed in sub-Saharan African countries but middle- and low-income Asian countries have lagged behind in rotavirus vaccine introduction. We provide a mini-review of the leading newer-generation rotavirus vaccines and compare them with Rotarix and RotaTeq. We discuss how the development and future availability of newer-generation rotavirus vaccines that address the programmatic needs of poorer countries may help scale-up rotavirus vaccination where it is needed.

Subject Area

vaccinationinfections, viral

Languages

English
DOI
10.1080/21645515.2017.1403705
Published Date
14 Nov 2017
PubMed ID
29135339
Journal
Human Vaccines and Immunotherapeutics
Volume | Issue | Pages
Volume 14, Issue 2
Issue Date
2017-12-21
Dimensions Badge
Linked Content
Journal Article
|Commentary
Effectiveness of oral cholera vaccine in Haiti
2015 March 01 • Lancet Global Health